Manmeet Singh Soni's Insider Trades & SAST Disclosures
Manmeet Singh Soni's most recent trade in Pulse Biosciences Inc was a trade of 200,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Aug. 9, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Manmeet Singh Soni.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pulse Biosciences Inc | Manmeet Singh Soni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Manmeet Singh Soni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Manmeet Singh Soni | COO, CFO and President | Sale of securities on an exchange or to another person at price $ 168.41 per share. | 16 Aug 2023 | 1,755 | 62,621 (0%) | 0% | 168.4 | 295,566 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Manmeet Singh Soni | COO, CFO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jul 2023 | 75,000 | 75,000 | - | - | Class B common stock | |
| Reata Pharmaceuticals Inc ... | Manmeet Singh Soni | COO, CFO and President | 28 Jul 2023 | 75,000 | 139,376 (0%) | 0% | - | Class A common stock | ||
| Reata Pharmaceuticals Inc ... | Manmeet Singh Soni | COO, CFO and President | Sale of securities on an exchange or to another person at price $ 164.62 per share. | 28 Jul 2023 | 75,000 | 64,376 (0%) | 0% | 164.6 | 12,346,298 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Manmeet Singh Soni | COO, CFO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jul 2023 | 75,000 | 175,000 | - | - | Employee Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Manmeet Singh Soni | COO, CFO and President | 28 Jul 2023 | 75,000 | 0 | - | - | Class B common stock | ||
| Reata Pharmaceuticals Inc ... | Manmeet Singh Soni | COO, CFO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2023 | 6,000 | 64,376 (0%) | 0% | 0 | Class A common stock | |
| Pulse Biosciences Inc | Manmeet Singh Soni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Manmeet Singh Soni | COO, CFO and President | Sale of securities on an exchange or to another person at price $ 84.32 per share. | 15 May 2023 | 12,440 | 125,864 (0%) | 0% | 84.3 | 1,048,942 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Manmeet Singh Soni | COO, CFO and President | Sale of securities on an exchange or to another person at price $ 84.86 per share. | 15 May 2023 | 8,867 | 116,997 (0%) | 0% | 84.9 | 752,496 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Manmeet Singh Soni | COO, CFO and President | Sale of securities on an exchange or to another person at price $ 80.93 per share. | 15 May 2023 | 625 | 116,172 (0%) | 0% | 80.9 | 50,584 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Manmeet Singh Soni | COO, CFO and President | Sale of securities on an exchange or to another person at price $ 85.64 per share. | 15 May 2023 | 200 | 116,797 (0%) | 0% | 85.6 | 17,129 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Manmeet Singh Soni | COO, CFO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 50,000 | 138,304 (0%) | 0% | 0 | Class A common stock | |
| Reata Pharmaceuticals Inc ... | Manmeet Singh Soni | COO, CFO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 50,000 | 50,000 | - | - | Employee Stock Option (right-to-buy) | |
| Reata Pharmaceuticals Inc ... | Manmeet Singh Soni | COO, CFO and President | Sale of securities on an exchange or to another person at price $ 84.69 per share. | 07 Mar 2023 | 622 | 88,304 (0%) | 0% | 84.7 | 52,680 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Manmeet Singh Soni | COO, CFO and President | Sale of securities on an exchange or to another person at price $ 87.97 per share. | 03 Mar 2023 | 3,587 | 88,926 (0%) | 0% | 88.0 | 315,548 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Manmeet Singh Soni | COO, CFO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 75,000 | 75,000 | - | - | Employee Stock Option (right-to-buy) | |
| Reata Pharmaceuticals Inc ... | Manmeet Singh Soni | COO, CFO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 95,475 | 95,475 | - | - | Employee Stock Option (right-to-buy) | |
| Reata Pharmaceuticals Inc ... | Manmeet Singh Soni | COO, CFO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 23,513 | 92,513 (0%) | 0% | 0 | Class A common stock | |
| Pulse Biosciences Inc | Manmeet Singh Soni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 116,005 | 116,005 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Manmeet Singh Soni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Manmeet Singh Soni | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Manmeet Singh Soni | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 50,000 | 69,000 (0%) | 0% | 0 | Class A common stock | |
| Pulse Biosciences Inc | Manmeet Singh Soni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Manmeet Singh Soni | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 24,000 | 24,000 | - | - | Employee Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Manmeet Singh Soni | COO and CFO | Purchase of securities on an exchange or from another person at price $ 100.22 per share. | 14 Aug 2020 | 2,000 | 2,000 (0%) | 0% | 100.2 | 200,440 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Manmeet Singh Soni | COO and CFO | Purchase of securities on an exchange or from another person at price $ 100.19 per share. | 14 Aug 2020 | 1,000 | 3,000 (0%) | 0% | 100.2 | 100,190 | Class A common stock |
| Pulse Biosciences Inc | Manmeet Singh Soni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges